Neos Therapeutics
Grand Prairie, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
SL
Steven LutzVP Sales
CS
Carolyn SikesVP Clinical Affairs
AE
Arlen EwartController
RM
Russ McMahenVP Research and Development
SS
Stacie SwitzerAssistant Secretary
MC
Margaret CabanoVP Operations
GR
Greg RobitailleDirector
RE
Richard EisenstadtChief Financial Officer and Secretary
AH
Alan HellerChairman
AM
Asif MughalVP Quality Assurance
MT
Mark TenglerChief Technology Officer
RI
Ralph IannelliDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$20.6MraisedFeb 2015 · 27 investors · PharmaceuticalsRule 506(b)
▶$20.6MraisedFeb 2015 · 27 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven LutzExecutive Officer
- Carolyn SikesExecutive Officer
- Arlen EwartExecutive Officer
- Russ McMahenExecutive Officer
- Stacie SwitzerExecutive Officer
- Margaret CabanoExecutive Officer
- Greg RobitailleDirector
- Richard EisenstadtExecutive Officer
- Alan HellerDirector
- Asif MughalExecutive Officer
- Mark TenglerExecutive Officer
- Ralph IannelliDirector
- Vipin GargExecutive Officer, Director
- Bryant FongDirector
- Edward SchnipperDirector
- Dorothy EngelkingExecutive Officer
- Offering amount
- $20.6M
- Amount sold
- $20.6M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.